Novel mutations of the von hippel-lindau tumor-suppressor gene and rare dna hypermethylation in renal-cell carcinoma cell lines of the clear-cell type

International Journal of Cancer

Volumn 87, Issue 5, 2000, Pages 650-653

  Meyer, Alexander J ^a   Hernandez, Ana ^a   Florl, Andrea R ^a   Enczmann, Jürgen ^a   Gerharz, Claus Dieter ^a   Schulz, Wolfgang A ^a   Wernet, Peter ^a   Ackermann, Rolf ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CARCINOMA CELL; DNA METHYLATION; FRAMESHIFT MUTATION; GENE MUTATION; GENE SILENCING; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOP CODON; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, RENAL CELL; DNA METHYLATION; EXONS; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MUTATION; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0033855204     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000901)87:5<650::AID-IJC5>3.0.CO;2-3     Document Type: Article

References (18)

1. ANTONARAKIS, S., and THE NOMENCLATURE WORKING GROUP, Recommendations for a nomenclalure system for human gene mutations. Hum. Mutation. 11, 1-3 (1998).
2. BEROUD, C., JOLY, D., GALLOU, C., STAROZ, F., ORFANELLI, M.T. and JUNIEN, C., Software and database for the analysis of mutations in the VHL gene. Nucl. Acids Res., 26, 256-258 (1998).
3. BRÜNING, T., WEIRICH, G., HORNAUER, M.A., HÖFLER, H. and BRAUCH, H., Renal cell carcinomas in trichloroethylene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau tumour suppressor gene. Arch. Toxicol., 71, 332-335 (1997).
4. CLIFFORD, S.C., PROWSE, A.M., AFFARA, N.A., BUYS, C.H.C.M. and MAHER, E.R., Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumorigenesis. Genes Chromosomes Cancer, 22, 200-209 (1998).
5. DUAN, D.R., PAUSE, A. and BURGESS, W.H., Inhibition of transcription elongation by the VHL tumor suppressor protein. Science, 269, 1402-1406 (1995).
6. FOSTER, K., PROWSE, A.D.B., FLEMING, S., HUISBEEK, M.M.F., CROSSFY, P.S., RICHARDS, F.M., CAIRNS, P., AFFARA, N.A., FERGUSON-SMITH, M.A. and BUYS, C.H.C.M., Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familiar clear cell renal carcinoma. Hum. Mol. Genet., 3, 2169-2173 (1994).
7. GERHARZ, C.-D., HILDEBRANT, B., MOLL, R., RAMP, U., SARBIA, M., STÖRKEL, S., KOLDOVSKY, P. and GABBFRT, H.E., Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterization of four permanent cell lines. Brit. J. Cancer, 74, 1605-1614 (1996).
8. GERHARZ, C.-D., MOLL, R., STÖRKEL, S., RAMP, U., HILDEBRAND, B., MOLSBERGER, G., KOLDOVSKY, P. and GABBERT, H.E., Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma. Amer. J. Pathol., 146, 953-962 (1995).
9. GERHARZ, C.-D., MOLL, R., STÖRKEL, S., RAMP, U., THOENES, W. and GABBERT, H.E., Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of humun renal cell carcinoma in vitro. Amer. J. Pathol., 142, 851-859 (1993).
10. GNARRA, J.R., and 23 OTHERS, Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature (Genet.), 1, 85-90 (1994).
11. HERMAN, J.G., GRAFF, J.R., MYÖHÄNEN, S., NELKIN, B.D. and BAYLIN, S.B., Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. nat. Acad. Sci. (Wash.), 93, 9821-9826 (1996).
12. HERMAN, J.G., LATIF, F., WENG, Y., LERMAN, M.I., ZBAR, B., LIU, S., SAMID, D., DUAN, D.S., GNARRA, J.R., LINEHAN, W.M. and BAYLIN, S.B., Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. nat. Acad. Sci. (Wash.), 91, 9700-9704 (1994).
13. KOVACS, G., Molecular cytogenetics of renal tumours. Adv. Cancer Res., 62, 89-124 (1993).
14. MYDLO, J.H., Growth factors and renal cancer: characterization and therapeutic implications. World J. Urol., 356-363 (1995).
15. PAUSE, A., LEE, S., LONERGAN, K.M. and KLAUSNER, R.D., The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc. nat. Acad. Sci. (Wash.), 95, 993-998 (1998).
16. STEBBINS, C.E., KAELIN, W.G. and PAVLETICH, N.P., Structure of the VHL-ElonginC-ElonginB complex: implication for VHL tumor suppressor function. Science, 284, 455-461 (1999).
17. WENZEL, M., ENCZMANN, J., UHRBERG, M., HERNANDEZ, A., WIESE, U., ACKERMANN, R., SCHMITZ-DRAEGER, B., EBERT, T. and WERNET, P., Screening for renal carcinoma associated mutations in the von Hippel-Lindau tumor suppressor gene by temperature gradient gel electrophoresis. Electrophoresis, 18, 45-51 (1997).
18. WHALEY, J.M., and 12 OTHERS, Germ-line mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Amer. J. hum. Genet., 55, 1092-1102 (1994).